The ROE as of November 2024 (TTM) for Vaccitech plc (VACC) is -18.36%

According to Vaccitech plc’s latest financial reports and current stock price. The company's current ROE is -18.36%. This represents a change of 111.72% compared to the average of -8.67% of the last 4 quarters.

Vaccitech plc (VACC) Historical ROE (quarterly & annually)

How has VACC ROE performed in the past?

The mean historical ROE of Vaccitech plc over the last ten years is 30.59%. The current -18.36% ROE has changed -160.02% with respect to the historical average. Over the past ten years (40 quarters), VACC's ROE was at its highest in in the March 2021 quarter at 28.75%. The ROE was at its lowest in in the June 2023 quarter at -10.96%.

Vaccitech plc (VACC) ROE by Quarter and Year

Discovering the peaks and valleys of Vaccitech plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vaccitech plc (VACC) Average ROE

How has VACC ROE performed in the past?

The current ROE of Vaccitech plc (VACC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vaccitech plc (VACC) ROE vs. Peers

How is VACC’s ROE compared to its peers?

Vaccitech plc’s ROE is greater than Molecular Partners AG (-39.16%), greater than MediciNova, Inc. (-20.70%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Champions Oncology, Inc. (323.52%), greater than Cyteir Therapeutics, Inc. (-9.44%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Talaris Therapeutics, Inc. (-14.93%), greater than Adicet Bio, Inc. (-53.85%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Vor Biopharma Inc. (-101.14%), greater than Tyra Biosciences, Inc. (-25.14%), greater than Third Harmonic Bio, Inc. (-4.28%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Revolution Medicines, Inc. (-33.67%), greater than Design Therapeutics, Inc. (-18.01%), greater than Achilles Therapeutics plc (-54.57%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than Magenta Therapeutics, Inc. (-14.27%), greater than Graphite Bio, Inc. (-57.96%), greater than CytomX Therapeutics, Inc. (-41.34%), greater than Instil Bio, Inc. (-37.44%), less than Spero Therapeutics, Inc. (3.36%), greater than Assembly Biosciences, Inc. (-121.46%),

Build a custom stock screener for Vaccitech plc (VACC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccitech plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaccitech plc (VACC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaccitech plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.